According to an independent review, the contracts negotiated by the UK government for a swine flu vaccine should have had get-out clauses to protect taxpayers’ money, experts say.

More than 30m doses are thought to be left over after one of the manufacturers, GlaxoSmithKline (GSK), refused requests for the contract to be torn up.

For more about how the swine flu vaccine has cost the taxpayer millions follow this link

  

talkhealth

This is the talkhealth blog spot, where we post on a wide range of health conditions, topics, issues and concerns. We post when we see something that we believe is of interest to our visitors. Our posts do not reflect any particular view or standpoint of talkhealth, but are merely to raise attention and awareness.

Add a comment

Your email address will not be published. Required fields are marked *